Bismuth

Bismuth is one of those metals almost no one thinks about until something goes wrong. It shows up in over-the-counter stomach remedies, in prescription ulcer regimens for H. pylori, and occasionally in cosmetics or industrial exposures. In healthy adults with no unusual exposure, your body carries essentially none of it, which is exactly what makes a 24-hour urine test useful: it gives you a clean, quantitative window into whether bismuth is entering your system.

This test is exploratory rather than a standard-of-care screen. It measures how much bismuth your kidneys cleared over a full day of urine collection, which is more informative than a random spot sample for trace elements. If you are taking bismuth-containing medications, have taken them for months, or suspect an environmental source, this is one of the clearer ways to see what your body is actually excreting.

What the Test Is Really Measuring

Your kidneys are constantly filtering blood and sending waste out through urine. When bismuth enters your body, whether from a swallowed tablet or another source, a portion of what gets absorbed eventually shows up in urine. Collecting every drop of urine you produce over 24 hours captures the full daily output of bismuth your body is clearing, rather than a single moment in time.

In a study of 111 healthy adults with normal exposure, bismuth was undetectable in 87% of 24-hour urine samples. That baseline matters. It means detectable bismuth is unusual in the general population and is worth taking seriously as a sign of ongoing exposure, though a detectable value alone does not prove toxicity. The evidence here is limited: this is a research and reference-range marker, not a standard clinical test with established cutpoints for disease.

Why Bismuth Exposure Matters

Bismuth compounds have been used medically for over a century. For most short-term users of Pepto-Bismol or a two-week H. pylori course, absorption is low and clearance is relatively quick. The problem appears with sustained or high-dose exposure, because bismuth does not simply pass through. It can be sequestered in tissues over time.

In a study of oral tripotassium dicitrato bismuthate (an ulcer treatment), 24-hour urinary bismuth excretion rose roughly 349-fold during a 6-week course, even though same-day plasma levels remained modest (below 50 µg/L). The extra bismuth in urine came from what had been stored in tissues during weeks of dosing. This is direct human evidence that repeated bismuth exposure accumulates and that urine excretion reflects both recent intake and the release of previously stored bismuth.

Kidney Involvement

Because bismuth clears through the kidneys, they are also the organ most exposed to it. A systematic review of human evidence concluded that bismuth exposure can cause kidney damage, particularly in people with a history of renal impairment, and that bismuth should be considered nephrotoxic when accumulation is significant. A pregnant adolescent case in the published literature developed acute kidney injury from bismuth intoxication, which resolved with treatment including chelation and dialysis.

None of this means occasional Pepto-Bismol is dangerous. It means that if your kidneys are already impaired, or if you have been on high-dose or long-duration bismuth therapy, the same dose that is safe for someone else can accumulate in you. Renal function directly shapes how much bismuth your body clears versus retains.

Neurological Signals

The most concerning historical outcome of bismuth accumulation is encephalopathy, a brain dysfunction syndrome. A published case report describes a 44-year-old woman who used bismuth subsalicylate for roughly 20 years, developed encephalopathy with myoclonus, and recovered completely within weeks of stopping the drug. In some short-course dosing studies, transient peak plasma bismuth exceeded the 50 µg/L threshold sometimes cited as a marker for neurotoxicity, but regulatory reviews note that short-term transient peaks above 50 µg/L have not been linked to clinical neurotoxicity. The syndrome has been most reliably described with sustained high-dose exposure over months to years, not brief spikes.

Bismuth encephalopathy is rare. But it is one of the few metal-driven neurological syndromes that is both reversible and preventable, and knowing your urinary output during long-term bismuth use is a way to catch accumulation before symptoms appear.

Why a 24-Hour Collection Beats a Spot Sample

For trace elements like bismuth, random spot urine samples can be misleading. Your excretion varies through the day, and the concentration of any single sample depends on how hydrated you were when you gave it. The 24-hour collection captures your total daily excretion, which is described in the clinical literature as the most informative laboratory indicator of trace element status.

A common workaround for spot samples is to normalize the result to urinary creatinine, but the research shows this can distort results in ways that matter. Trace element to creatinine ratios have to be interpreted with separate ranges for men and women, because women excrete less creatinine and end up with higher-looking ratios even when their actual excretion is lower. A full 24-hour collection sidesteps this problem.

When Results Can Be Misleading

A single reading can be distorted by several things. Lead with the most common pitfalls:

• Incomplete collection: if you miss even one urination during the 24 hours, your total excretion looks artificially low. The single most important thing you can do is capture every void.
• Recent bismuth-containing medication: swallowing Pepto-Bismol, De-Nol, or an H. pylori quadruple regimen the day before or during collection will substantially raise your urinary bismuth. This is not a false positive, but it is important to know why the number is elevated.
• Impaired kidney function: if your kidneys are not clearing normally, urine output does not reflect body burden accurately, and bismuth may be accumulating in tissue rather than showing up in urine.
• Gadolinium contrast agents from a recent MRI: analytical work on human urine shows Gd-based contrast agents can produce spectral interferences on trace element mass spectrometry (documented most clearly for selenium and platinum, with the potential to affect other trace element measurements). If you had a contrast MRI in the days before your test, mention it.

Tracking Your Trend

A single reading is not enough to build a meaningful picture, particularly for a marker where most healthy people register nothing. What matters is your trend across time and across changes in exposure. If you are on a bismuth-containing medication, a baseline collection during use and a follow-up several weeks after stopping shows whether your body is actually clearing the metal. If you are investigating a suspected environmental source, tracking your number across removal of that source is the cleanest test of whether it was real.

A reasonable cadence: get a baseline test, retest 3 to 6 months later if you are making changes (stopping a medication, changing an environment, starting a targeted protocol), and at least annually if you have ongoing risk factors. Do not expect this number to change on a monthly timescale unless your exposure changes dramatically.

Decision Pathway for an Unexpected Result

If your 24-hour urine bismuth is detectable and you have no obvious source, the workup is a hunt for the exposure. Review every over-the-counter and prescription medication, particularly stomach and ulcer remedies. Consider cosmetic products, occupational exposures, and any recent bismuth-containing procedures. Pair this test with kidney function markers (creatinine, cystatin C, and eGFR) because bismuth clearance depends on kidney health and because the kidneys are the primary organ at risk.

If bismuth is significantly elevated alongside abnormal kidney markers, that combination is a stronger signal than either finding alone and is worth taking to a medical toxicologist or nephrologist. If you have neurological symptoms alongside elevated bismuth, that is a different and more urgent conversation. If the number is detectable but low and you have no symptoms or known exposure, retesting after a period of avoiding potential sources (including stopping any bismuth-containing OTC medications) is a reasonable next step to see whether the number moves. For chelation-based approaches, there is human trial evidence: a randomized comparison showed both DMSA and DMPS produced roughly a 50-fold increase in urinary bismuth excretion compared with untreated controls. This is a decision for a specialist, not a self-directed intervention.